Trial intelligence / Profile preview

Treximet Biomarker Evaluation in Menstrual Migraine

NCT01329562Phase 4Completed

Start
May 2011
Primary completion
Jun 2012
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of sumatriptan in menstrual migraine. Started May 2011; status: completed.

02

Drugs

sumatriptan
03

Conditions

menstrual migraine

Beyond the preview

Go deeper on NCT01329562.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01329562.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call